Home MedImmune

MedImmune

In operation
-
Biologics Developer
Basic
Enterprise Profile

Basic Information

MedImmune, LLC, a global biologics research and development subsidiary of AstraZeneca, is pioneering innovative research to explore new pathways in key therapeutic areas including respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, neuroscience, infectious diseases, and vaccines.
MedImmune, LLC
Maryland,United States of America
more than 500 people
January 01, 1987
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Department of Rheumatology and Immunology Tumor Cardiovascular Disease Infectious Diseases Metabolic Diseases # Nervous System Diseases Therapeutic Products Lupus Erythematosus
Application Scenarios
Innovative Drugs Monoclonal Antibody Bispecific Antibody Nucleic Acid Drugs